SEC Form 4 · accession 0001562180-15-000407
TriVascular Technologies, Inc. · TRIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Paul Scopa
Director
Period of report
May 22, 2015
Accepted (ET)
May 27, 2015 · 6:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001432732
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F2,F1 | $5.85 | May 22, 2015 | A | 10,000 | A | — | May 21, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F11/12th of the shares underlying the option vest and become exercisable in equal monthly installments through May 22, 2016.
- F2In connection with the reporting person's service as a non-employee director of the Company, such reporting person has been granted an award pursuant to the Company's amended compensation plan for non-executive directors. Pursuant to the Limited Partnership Agreement of MPM BioVentures IV-QP, LP, Mr. Scopa is not entitled personally to retain the award.